Drug Shortage Report for DALACIN C FLAVOURED GRANULES

Last updated on 2018-06-29 History
Report ID 48884
Drug Identification Number 00225851
Brand name DALACIN C FLAVOURED GRANULES
Common or Proper name Dalacin C Flavoured Granules
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) CLINDAMYCIN
Strength(s) 75MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration ORAL
Packaging size 1x40g
ATC code J01FF
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-05-17
Estimated end date
Actual end date 2018-06-28
Shortage status Resolved
Updated date 2018-06-29
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2018-06-29 English Compare
v12 2018-06-28 French Compare
v11 2018-06-28 English Compare
v10 2018-06-26 French Compare
v9 2018-06-26 English Compare
v8 2018-05-18 English Compare
v7 2018-05-17 French Compare
v6 2018-05-17 English Compare
v5 2018-05-15 English Compare
v4 2018-05-08 French Compare
v3 2018-05-08 English Compare
v2 2018-05-08 French Compare
v1 2018-05-08 English Compare

Showing 1 to 13 of 13